Around 2 Million Die From Work-Related Causes Annually, Finds UN Report
As many as 1.9 million people died from work-related diseases and injuries in 2016, according to the first joint estimates from the World Health Organization (WHO) and International Labour Organization (ILO). The majority of work-related deaths were due to respiratory and cardiovascular disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2021 Category: Pharmaceuticals Authors: Disha Shetty, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Bypass Is Best Bariatric Surgery to Reduce Cardiovascular Events Bypass Is Best Bariatric Surgery to Reduce Cardiovascular Events
Bariatric surgery is associated with a reduction in risk of major adverse cardiac events, and Roux-en-Y gastric bypass is linked to a greater reduction than sleeve gastrectomy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 16, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Heat-related cardiovascular morbidity and mortality in Switzerland: a clinical perspective - Schulte F, R öösli M, Ragettli MS.
AIMS: Previous studies found increased cardiovascular mortality during hot days, while emergency hospital admissions were decreasing. We explored potential underlying reasons by analysing clinically similar cardiovascular disease groups taking into account... (Source: SafetyLit)
Source: SafetyLit - September 16, 2021 Category: International Medicine & Public Health Tags: Environmental Issues, Climate, Geophysics Source Type: news

The Global Prevention of Cardiovascular Disease Among People Living with Diabetes: Leading with Heart The Global Prevention of Cardiovascular Disease Among People Living with Diabetes: Leading with Heart
Despite the high burden of cardiometabolic disease worldwide, there continues to be fragmented care and lack of ideal coordination at the public health level. The World Health Organization and World Heart Federation are making strides to address this and pave the way forward.ACC.org (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 15, 2021 Category: Cardiology Tags: Cardiology Article Source Type: news

High blood pressure symptoms: The common complaint that could signal condition
TRADITIONALLY, high blood pressure has been deemed a predominantly male problem, but emerging research suggests it is as significant for women as it is for men. Hypertension, which rarely shows symptoms, is considered an important precursor for a host of cardiovascular conditions. A common complaint, however, could foreshadow hypertension and all consequent ailments. (Source: Daily Express - Health)
Source: Daily Express - Health - September 15, 2021 Category: Consumer Health News Source Type: news

HeartFlow revenues surge in Q2
Strong demand for its products helped cardiovascular software developer HeartFlo...Read more on AuntMinnie.comRelated Reading: HeartFlow launches new trial of its FFR-CT software HeartFlow names new COO HeartFlow to go public in SPAC merger deal More Medicare patients to be covered for Heartflow Analysis HeartFlow touts PROMISE study findings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 14, 2021 Category: Radiology Source Type: news

Stress linked to high blood pressure and heart attacks
Stress really can trigger high blood pressure, heart attacks or a stroke, a study found. Adults with normal blood pressure but raised levels of stress hormones were more likely to develop high blood pressure and experience cardiovascular "events" compared with those who had lower levels. (Source: Daily Express - Health)
Source: Daily Express - Health - September 14, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases
NEW BRUNSWICK, N.J., September 13, 2021 – Data from two papers published in The Lancet Infectious Diseases demonstrated that the Johnson & Johnson (the Company) Ebola vaccine regimen, Zabdeno® (Ad26.ZEBOV) and Mvabea® (MVA-BN-Filo), generated robust humoral (antibody) immune responses in adults and children (ages 1-17) with the immune responses persisting in adults for at least two years. The data also showed that booster vaccination with Ad26.ZEBOV, administered to adults two years after the initial vaccination, induced a strong anamnestic (immune) response within seven days. These findings support the p...
Source: Johnson and Johnson - September 13, 2021 Category: Pharmaceuticals Source Type: news

The interplay between child maltreatment and stressful life events during adulthood and cardiovascular problems-a representative study - Clemens V, B ürgin D, Huber-Lang M, Plener PL, Brahler E, Fegert JM.
Psychological stress is a major risk factor for cardiovascular diseases. While the relevance of early life stress, such as that which is due to child maltreatment (CM), is well known to impact individual stress responses in the long-term, and data on the i... (Source: SafetyLit)
Source: SafetyLit - September 13, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

High blood pressure: The five most beneficial exercises for hypertension and what to avoid
BLOOD PRESSURE is a key consideration in the prevention of cardiovascular disease, with a quarter of all heart attacks directly attributed to hypertension. In its severe stages, the condition can feature nosebleeds, fatigue and vision problems. While most forms of physical activity have blood pressure-lowering effects, the optimal type of exercise is still often disputed. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2021 Category: Consumer Health News Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

ERLEADA ® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
September 11, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep PSA response and prolonged survival in both metastatic castration-sensitive prostate cancer (mCSPC) and nmCRPC. The post-hoc analysis also...
Source: Johnson and Johnson - September 12, 2021 Category: Pharmaceuticals Source Type: news

Sharing Mayo Clinic: Heart health for myself and my family
Sandra Driggers is a nurse at Mayo Clinic in Florida who works in the Division of Cardiovascular Medicine. This is her heart health story. ______________________________ I struggled with my weight for most of my life. I never really gave a lot of thought to being healthy (or unhealthy), or about how my weight and lifestyle played a role in my future health.But a little over 16 years ago, I had a heart attack. Back then,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 12, 2021 Category: Databases & Libraries Source Type: news

STUDY: Covid "vaccine" spike proteins damage heart cells, alter heart function... and they're in the booster shots, too
(Natural News) A new study brings further clarity as to the effects of Wuhan coronavirus (Covid-19) “vaccine” spike proteins on the human cardiovascular system. According to science, vaccine-induced spike proteins change heart cells, disrupting their functionality. This was observed specifically in the small blood vessel cells that surround the heart, although it was also found... (Source: NaturalNews.com)
Source: NaturalNews.com - September 10, 2021 Category: Consumer Health News Source Type: news

Start your day the healthiest way with blood orange juice: Fruit can improve cardiovascular health
Blood oranges provide the best antioxidant hit and have been linked to improved cardiovascular health, cancer prevention and improved cognitive function, experts say. (Source: the Mail online | Health)
Source: the Mail online | Health - September 10, 2021 Category: Consumer Health News Source Type: news

Fecal Transplants: a New Treatment for IBD
Linda Ann Sasser has had ulcerative colitis since she was 20, but it wasn’t until May 2019, about 30 years later, that her condition hit a low point: not only did she have a major flare-up of chronic inflammatory bowel disease (IBD), but on top of it, she had Clostridioides difficile (or C. diff), a highly contagious bacterial infection that causes severe diarrhea and inflammation of the colon. “I became really, really sick with bloody diarrhea 30 times a day and chronic stomach pain,” Sasser says. While hospitalized for 12 days, she was given oral steroid medications, which didn’t help, then IV ste...
Source: TIME: Health - September 9, 2021 Category: Consumer Health News Authors: Stacey Colino Tags: Uncategorized Disease feature Source Type: news

Intelerad buys U.K. enterprise imaging firm Insignia
Enterprise imaging and software developer Intelerad Medical Systems' aggressiv...Read more on AuntMinnie.comRelated Reading: Intelerad signs contract with LifeBridge Health Intelerad buys workflow firm Heart Imaging Technologies Intelerad expands cardiovascular market presence with Lumedx buy Teleradiology sector provides clear ray of hope in COVID-19 era Intelerad continues growth spree, buys Digisonics EnvoyAI, TeraRecon, and Insignia to bring AI to U.K. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 8, 2021 Category: Radiology Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

The Key Role of BP Lowering in Cardiovascular Prevention The Key Role of BP Lowering in Cardiovascular Prevention
A new study confirms the benefits of anti-hypertensive treatment regardless of baseline BP, challenging the concept that BP-lowering treatment is only effective when BP is above a certain threshold.European Heart Journal (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 6, 2021 Category: Intensive Care Tags: Cardiology Journal Article Source Type: news

Neuroendocrine and cardiovascular activation during aggressive reactivity in dogs - Gobbo E, Zupan Šemrov M.
Our aim was to investigate cardiovascular activation by measuring changes in facial and body surface temperature using infrared thermography, and neuroendocrine activation using salivary cortisol (CORT) and serotonin concentration (SER) in dogs exhibiting ... (Source: SafetyLit)
Source: SafetyLit - September 4, 2021 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

' Quadpill' Bests Monotherapy for Initial BP Lowering: QUARTET'Quadpill' Bests Monotherapy for Initial BP Lowering: QUARTET
The study emphasizes the importance, potential benefits, and simplicity of low-dose BP-lowering drugs combined in one pill, as part of a strategy to reduce cardiovascular risk, says an expert.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 3, 2021 Category: Drugs & Pharmacology Tags: Cardiology News Source Type: news

Will the SSaSS Trial Silence the Salt Skeptics? Will the SSaSS Trial Silence the Salt Skeptics?
Bruce Neal gives the lowdown on the massive SSaSS trial that showed a reduction in stroke and cardiovascular events among at-risk people in rural China who used a salt substitute instead of regular table salt.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 2, 2021 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Stroke: The lifestyle habit increasing your risk of the life-threatening condition
STROKE is one of the leading causes of death globally, with a third of stroke sufferers succumbing to an incident. An acute event is characterised by weakness, speech difficulty and confusion, and can leave a person severely disabled. A new study has highlighted one lifestyle habit that could have detrimental repercussions for cardiovascular health, significantly hiking the risk of stroke. (Source: Daily Express - Health)
Source: Daily Express - Health - September 2, 2021 Category: Consumer Health News Source Type: news

PharmaPoint Signs Contract with Federally Qualified Health Center...
XchangePoint chosen as solution to improve outcomes for cardiovascular patients(PRWeb September 02, 2021)Read the full story at https://www.prweb.com/releases/pharmapoint_signs_contract_with_federally_qualified_health_center_fqhc_mountain_laurel_medical_center/prweb18170538.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 2, 2021 Category: Pharmaceuticals Source Type: news

Periodontitis May Raise Risk for New Cardiovascular Events
WEDNESDAY, Sept. 1, 2021 -- Periodontitis is associated with increased odds of new cardiovascular (CV) events, according to a study presented at the European Society of Cardiology Congress 2021: The Digital Experience, held virtually from Aug. 27 to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2021 Category: Pharmaceuticals Source Type: news

New ESC Guidelines on CVD Prevention New ESC Guidelines on CVD Prevention
The new guidelines adopt the SCORE2 and SCORE2-OP algorithms to gauge long-term cardiovascular risk and introduce a stepwise treatment-intensification approach.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 1, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Janssen Announces U.S. FDA Approval of INVEGA HAFYERA ™(6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia in adults. Before transitioning to INVEGA HAFYERA™, patients must be adequately treated with INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least four months, or INVEGA TRINZA® (3-month paliperidone palmitate) for at least one 3-month injection cycle.1 The FDA a...
Source: Johnson and Johnson - September 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cholesterol injection deal with NHS aims to save 30,000 lives
Health service to target use of Novartis drug inclisiran in bid to prevent cardiovascular disease in England (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 31, 2021 Category: Pharmaceuticals Source Type: news

CV Safety Study of Cancer Therapy Attracts Attention CV Safety Study of Cancer Therapy Attracts Attention
Although the first global trial to compare the cardiovascular (CV) safety of two therapies for prostate cancer proved inconclusive, it was"a model for interdisciplinary collaboration" says investigator.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 31, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

GP practices to deliver 200,000 doses a year of new anti-cholesterol jab
GP practices in England could deliver 200,000 doses a year of an anti-cholesterol jab for people with high cholesterol or a history of cardiovascular disease, after NICE backed the drug in draft guidance. (Source: GP Online News)
Source: GP Online News - August 31, 2021 Category: Primary Care Tags: Clinical News Source Type: news

Fixed-Dose Combination Therapies Reduce Cardiovascular Risk
TUESDAY, Aug. 31, 2021 -- Fixed-dose combination treatment consisting of blood pressure-lowering medications and a statin yields reduction in cardiovascular risk, according to research published online Aug. 29 in The Lancet to coincide with the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 31, 2021 Category: Pharmaceuticals Source Type: news

Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to Advancing Science for Genitourinary Cancers at AUA 2021
August 31, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple company-sponsored presentations in prostate and bladder cancers will be highlighted at the virtual 2021 American Urological Association Annual Meeting (AUA 2021), September 10-13. “Janssen maintains a strong commitment to advancing innovation and new therapeutic options for patients with genitourinary malignancies. As the treatment of genitourinary cancers becomes more complex, we continue to work with urologists and their teams to improve outcomes for patients across the continuum of disease...
Source: Johnson and Johnson - August 31, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

SGLT2i and GLP-1RA for CVD and Kidney Disease Risk Reduction SGLT2i and GLP-1RA for CVD and Kidney Disease Risk Reduction
Despite proven efficacy in cardiovascular and kidney disease risk reduction, both SGLT-2i and GLP-1RA remain underused by cardiologists in clinical practice, according to this commentary.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa
This study is being conducted in the Americas and Europe where different strains of HIV are circulating. Given these differentiating factors and following consultations with the Mosaico study independent Data and Safety Monitoring Board (DSMB), it was decided that the Mosaico study will continue at this time. “We are extremely grateful to the women who volunteered for the Imbokodo study, and to our partners, including the people on the frontlines, all of whom are contributing every day to this enduring quest to make HIV history,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scien...
Source: Johnson and Johnson - August 31, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients
Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients. This is the finding of a study by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), published today in the Journal of the American College of Cardiology (JACC). (Source: World Pharma News)
Source: World Pharma News - August 30, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Salt Substitute Reduces Stroke, CV Events, and Death Salt Substitute Reduces Stroke, CV Events, and Death
Switching from regular salt to a low-sodium salt substitute has major public health benefits, including a reduction in stroke, cardiovascular events, and death, the new landmark SSaSS shows.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 29, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

A snack to reduce Alzheimer’s & cardiovascular diseases by 25 percent says new study
LONGEVITY and food will almost always go hand in hand. With this in mind, can a certain food help to increase your lifespan? A study has found one snack to be so powerful it can not only help with longevity but also reduce your risk of Parkinson's, Alzheimer's and cardiovascular diseases, whilst also lowering your cholesterol levels. (Source: Daily Express - Health)
Source: Daily Express - Health - August 29, 2021 Category: Consumer Health News Source Type: news

Low-to-Moderate Coffee Intake in Midlife Tied to Heart Benefits Low-to-Moderate Coffee Intake in Midlife Tied to Heart Benefits
A new study found no adverse effects of coffee consumption on cardiovascular health and a possible benefit, based on cardiac MRI findings and stroke and mortality outcomes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 28, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

New-Data-Finerenone-protection-patients-chronic-kidney-disease-2-diabetes-cardiovascular-events
(Source: Bayer Company News)
Source: Bayer Company News - August 28, 2021 Category: Pharmaceuticals Source Type: news

emperor-preserved-heart-failure-full-data
Landmark trial demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction  In this clinical first for adults with heart failure with preserved ejection fraction, empagliflozin demonstrated an impressive 21  percent relative risk reduction in the composite primary endpoint of cardiovascular death or hospitalization for heart failure1The benefit in the primary endpoint was independent of ejection fraction or diabetes status1Empagliflozin also reduced the relative risk of first and recurrent hospitalizations for h...
Source: Boehringer Ingelheim Corporate News - August 27, 2021 Category: Research Source Type: news

AHA Targets Rising Prevalence of Sleep Apnea in Children AHA Targets Rising Prevalence of Sleep Apnea in Children
Obstructive sleep apnea is becoming more common in children and adolescents as the prevalence of obesity increases, but it may also be a preventable risk factor for cardiovascular disease.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 26, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Heart attack: The sign when you brush your teeth that could indicate you’re at risk
CARDIOVASCULAR diseases are one of the leading causes of death worldwide, claiming an estimated 17.9 million lives each year. More than four out of five cardiovascular deaths are due to heart attacks. While the early signs of a heart attack are few, one sign indicating your risk could arise while you're brushing your teeth. (Source: Daily Express - Health)
Source: Daily Express - Health - August 25, 2021 Category: Consumer Health News Source Type: news

Liraglutide Reduces Visceral Fat in Overweight, Obese Adults
WEDNESDAY, Aug. 25, 2021 -- For overweight and obese adults at high cardiovascular risk, liraglutide reduces visceral adipose tissue, according to a study published online Aug. 3 in The Lancet Diabetes& Endocrinology. Ian J. Neeland, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 25, 2021 Category: Pharmaceuticals Source Type: news

Coronary Artery Disease:'Gout' in the Artery? Coronary Artery Disease:'Gout' in the Artery?
In this commentary, the authors compare and contrast gout and atherosclerotic cardiovascular disease. What, if anything, do they have in common?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 25, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine
NEW BRUNSWICK, N.J., August 25, 2021 – Johnson & Johnson today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine. In July, the Company reported interim Phase 1/2a data published in the New England Journal of Medicine that demonstrated neutralizing antibody responses generated by the Johnson & Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization. In anticipation of the potential need for boosters, the Company conducted two Phase 1/2a studies in individuals...
Source: Johnson and Johnson - August 25, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

DiA secures $14M in new funding
Ultrasound artificial intelligence software developer DiA Imaging Analysis ha...Read more on AuntMinnie.comRelated Reading: Circle Cardiovascular, DiA Imaging Analysis to partner Konica Minolta, DiA add echo AI analysis of COVID-19 FDA clears DiA's cardiac ultrasound AI DiA gets FDA nod, CE Mark for AI-based ultrasound tools DiA partners with IBM Watson on AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2021 Category: Radiology Source Type: news

Could scanning more Black people boost benefits of lung screening?
The mortality benefit of low-dose CT (LDCT) lung cancer screening programs coul...Read more on AuntMinnie.comRelated Reading: Racial disparities in mammography rose in Calif. during pandemic CT lung cancer screening guidelines are changing Rural areas lack access to CT lung cancer screening AI predicts cardiovascular risk on LDCT lung cancer screening IASLC: Screen nonsmokers for lung cancer, too (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2021 Category: Radiology Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

High cholesterol: The food that could lower cholesterol levels when added to your diet
HIGH cholesterol can be very detrimental to cardiovascular health, so it is crucial to maintain levels within healthy ranges. A new study has identified a new food that could help lower dangerous cholesterol. (Source: Daily Express - Health)
Source: Daily Express - Health - August 23, 2021 Category: Consumer Health News Source Type: news